Back

Epidemiology and clinical characteristics of patients eligible for novel cardiovascular preventive therapies: a real-world analysis of data from general practice doctors in Italian population

29 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Remodelling under pressure: how kidney disease shapes the heart Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Lorenzo Giovanni Mantovani

University of Milan-Bicocca, Monza (Italy)

7 More presentations in this session

Presentation thumbnail
Prognostic stratification with composite insulin resistance inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses
Mr Z. Ye (Beijing, CN)
Abstract
Presentation thumbnail
Clinical and demographic factors associated with cardiac remodelling in renal transplant recipients
Doctor S. Iliescu (Iasi, RO)
Abstract
Presentation thumbnail
Dyskalemia, cardiac structure and function, and risk of adverse cardiovascular events in patients with chronic kidney disease
Doctor I. Try Lenz (Copenhagen, DK)
Abstract
Presentation thumbnail
Plasma lipoprotein(a) levels are associated with chronic kidney disease and venous calcification in patients undergoing coronary artery bypass grafting
Ms Y. Shin (KR)
Abstract
Presentation thumbnail
Diastolic dysfunction and structural response to SGLT2 inhibition in chronic kidney disease: the DECODE-CKD trial
Doctor K. Bartholdy (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Remodelling under pressure: how kidney disease shapes the heart

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Unconventional risk factors in cardiovascular diseases: a population-based Italian cohort study
4 April 2025
thumbnail
Congress Presentation
Guideline-directed medical therapy use in patients with incident comorbid heart failure and chronic kidney disease (The CaRe Study)
1 September 2025
thumbnail
Congress Presentation
Prevalence of systemic inflammation in individuals with atherosclerotic cardiovascular disease: baseline characteristics from the SELECT, SOUL and FLOW phase 3 trials of semaglutide
25 August 2023
thumbnail
Congress Presentation
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources